info@synedica.vip

Important Notice

The products are for research and development purposes only.

RETA X GLOW

Synedica RETA X GLOW® Injection Pen Kit is a dual-pen formulation designed to support metabolic wellness alongside skin rejuvenation, hair vitality and cellular renewal.

Retatrutide is a triple agonist peptide currently being studied for its role in appetite regulation, metabolic health and weight-management support. It acts on GLP-1, GIP and glucagon receptors and is intended for use only under appropriate clinical guidance.

GLOW GHK-Cu is widely recognised for its role in supporting collagen production, improving skin elasticity and promoting tissue repair. It contributes to healthier-looking skin and supports hair follicle function by encouraging cellular renewal.

Synedica RETA X GLOW® Injection Pen Kit contains 2 pens, 12 disposable needles and 2 instruction booklets.

Each kit contains 1 Retatrutide pen containing 40mg and 1 GLOW GHK-Cu pen containing 35mg.

The Retatrutide pen contains 40mg total active content.

The GLOW GHK-Cu pen contains 35mg total active content.

Recommended dosage and titration should be followed only in accordance with the supplied instructions and guidance from a qualified healthcare professional.

Suitable R&D Applications

flask

Stability Testing

  • • Thermal, enzymatic, and oxidative degradation studies
  • • Shelf-life evaluation & formulation robustness
beaker

Formulation Development

  • • Enhances solubility, bioavailability, and structural integrity
  • • Tailored for injectable, topical, and research-grade use
puzzle

Excipient Compatibility Testing

  • • Evaluates interactions between peptides & inactive components
  • • Ensures safety, stability, and performance
lock

Protease Resistance Evaluation

  • • Evaluates interactions between peptides & inactive components
  • • Ensures safety, stability, and performance
capsule

Encapsulation & Carrier Systems

  • • Liposomes, microspheres, and other delivery vehicles
  • • Protects peptides & enables controlled release
route

Administration Route Assessment

  • • Parenteral delivery (injectables)
  • • Dermal absorption (cosmetic/topical)
  • • In vitro research applications